HopeStage
Back to all studies
RecruitingNCT05377177

Comparing bilateral and unilateral theta-burst brain stimulation for suicidal thoughts in treatment-resistant depression

About this title

Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI

Read the official source — NCT05377177
Device studyAges 18–70United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

Listed locations
San DiegoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 2, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
76
Sponsor
University of California, San Diego
Sponsor type
University
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT05377177
Official title
Show the full official title

Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression (COMBAT-SI)

Recruitment & locations

Currently recruiting

San Diego

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, San Diego, a university.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies